Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

COVID-19 × monalizumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 4 Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 2 Small Cell Lung Carcinoma 2 Lung Neoplasms 2 Head and Neck Neoplasms 2 Non-Muscle Invasive Bladder Neoplasms 1 Neoplasm Metastasis 1 Myeloproliferative Disorders 1 Leukemia, Myeloid, Acute 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Laryngeal Diseases 1 Infections 1 Hematologic Neoplasms 1 Esophageal Squamous Cell Carcinoma 1 COVID-19 1 Breast Neoplasms 1 Anemia, Refractory, with Excess of Blasts 1 Adenocarcinoma Of Esophagus 1

Interventions

Standard of Care 7 Surveys and Questionnaires 6 COVID-19 Vaccines 6 Blood Specimen Collection 6 Specimen Handling 5 BNT162 Vaccine 5 2019-nCoV Vaccine mRNA-1273 4 Surgical Procedures, Operative 3 Practice Guidelines as Topic 3 Hydroxychloroquine 3 tocilizumab 2 sotrovimab 2 sinovac COVID-19 vaccine 2 cilgavimab and tixagevimab drug combination 2 Pandemic Preparedness 2 Data Collection 2 CVnCoV COVID-19 vaccine 2 COH04S1 COVID-19 vaccine 2 Azithromycin 2 selinexor 1 remdesivir 1 regorafenib 1 proxalutamide 1 palbociclib 1 ogalvibart 1 monalizumab 1 lenzilumab 1 heterologous prime boost COVID-19 vaccination 1 crexavibart 1 ciclesonide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04333914 2022-09-30

IMMUNONCOVID

Centre Leon Berard

Phase 2 Completed

COVID-19, Infections, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡